Leukemia Relapses May Arise From Specialized Cells
Leukemia Relapses May Arise From Specialized Cells

Leukemia Relapses May Arise From Specialized Cells

Targeting the transient group of cells could prevent recurrence of the disease.

Sukanya Charuchandra
Sukanya Charuchandra

Originally from Mumbai, Sukanya Charuchandra is a freelance science writer based out of wherever her travels take her. She holds master’s degrees in Science Journalism and Biotechnology. You can read...

View full profile.


Learn about our editorial policies.

Dec 1, 2018

ABOVE: Leukemic regenerating cells, rather than leukemia stem cells, may be responsible for relapses after chemotherapy.
© ISTOCK.COM, MARILYN NIEVES

EDITOR'S CHOICE IN DISEASE & MEDICINE

The paper

A.L. Boyd et al., “Identification of chemotherapy-induced leukemic-regenerating cells reveals a transient vulnerability of human AML recurrence,” Cancer Cell, 34:P483–98.e5, 2018.

Cancer researchers have long supposed that relapses of acute myeloid leukemia (AML) arise from a population of leukemia stem cells (LSC) that were dormant and therefore likely protected from chemotherapies that target dividing cells.

But when Mickie Bhatia of McMaster University in Canada and colleagues analyzed cancer cell populations from patient samples as well as those obtained from AML cells grafted into mice, they found that LSCs were depleted during chemotherapy. “By kinetically profiling the cells, we got a better impression of what was being killed during the chemotherapy, but also how it came back,” says Bhatia.

His team then...

“Maybe there’s a short window after induction [of] chemotherapy, where one could come in with a very specific therapy directed against this small population of leukemia regenerating cells,” says David Sykes, who studies AML at Massachusetts General Hospital and was not involved with this research. Sykes says the chances of finding similar target cell populations in other cancers is high.

Interested in reading more?

Leukemia Relapses May Arise From Specialized Cells

The Scientist ARCHIVED CONTENT

ACCESS MORE THAN 30,000 ARTICLES ACROSS MANY TOPICS AND DISCIPLINES

Become a Member of

Receive full access to more than 35 years of archived stories, digital editions of The Scientist Magazine, and much more!
Already a member?